235
Participants
Start Date
April 1, 2024
Primary Completion Date
February 18, 2025
Study Completion Date
February 18, 2025
Copper Cu 64 PSMA I&T
Radiopharmaceutical PET imaging tracer injected intravenously for the detection of PSMA expression.
James J. Peters VA Medical Center, The Bronx
Queens Hospital Center, Jamaica
Georgetown University Medical Center, Washington D.C.
Carolina Urologic Research Center, LLC, Myrtle Beach
University of Miami Miller School of Medicine, Miami
Biogenix Molecular, LLC, Miami
Florida Urology Partners, Tampa
University of Tennessee Medical Center, Knoxville
Cleveland Clinic, Cleveland
Urology of Indiana, LLC, Carmel
Indiana University Health Neuroscience Center, Indianapolis
University of Iowa, Iowa City
M Health Fairview University of Minnesota Medical Center, Minneapolis
Edward Hines Jr VA Hospital, Hines
SSM Health Saint Louis University Hospital, St Louis
John Cochran VA Medical Center, St Louis
Washington University School of Medicine, St Louis
The University of Kansas Hospital, Kansas City
XCancer, Omaha
Great Plains Health, Diagnostic Imaging, North Platte
Excel Diagnostics and Nuclear Oncology Center, Houston
Urology San Antonio, San Antonio
Tower Urology, Los Angeles
VA Greater Los Angeles Healthcare System, Los Angeles
Providence Saint John's Health Center, Santa Monica
Hoag Memorial Hospital Presbyterian, Newport Beach
Providence Medical Foundation, Fullerton
University of California, Irvine, Orange
San Francisco VA Medical Center, San Francisco
Stanford Hospital & Clinics, Stanford
VA Portland Health Care System, Portland
Curium US LLC
INDUSTRY